11.01.2017 • NewsPeopleCambrex

Tom Vadaketh Appointed as CFO of Cambrex

Cambrex has named Tom Vadaketh executive vice president and CFO, effective Jan. 20, 2017. Greg Sargen, current CFO at Cambrex, will transition to a newly-created role, EVP, corporate development and strategy.

Vadaketh was most recently the CFO of the Crosby Group, a private equity-owned manufacturer of rigging, lifting and material handling applications. Prior to that, he spent nine years in a variety of positions at Tyco International. Before joining Tyco, Vadaketh spent 15 years in a variety of roles at Proctor & Gamble.

Company

Logo:

Cambrex Corporation

One Meadowlands Plaza
07073 East Rutherford
US

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.